Bendamustin Ribosepharm

Medicinal product

(Invented) name

Bendamustin Ribosepharm

Active substance (s)

Bendamustino hidrochloridas

Strength

2,5 mg/ml

Pharmaceutical form

milteliai infuzinio tirpalo koncentratui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01AA09, Bendamustine

Marketing authorisation holder

UAB Edupharma, Lietuva

Date of authorisation

2019-04-17

Date of renewal

Documents

0868-001_Bendamustin Ribosepharm_2021-06-17.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Flakone yra	1 vnt.
Bendamustino hidrochloridas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101461	87564	1087564	flakonas	25 mg N1	ASPĮ	Receptinis	LT/L/19/0868/001	Tiekiama	-	-	No	-	-	Download
101462	87565	1087565	flakonas	100 mg N1	ASPĮ	Receptinis	LT/L/19/0868/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-08-18	Išregistruotas
2019-04-17	Registruotas